These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 1424521

  • 1. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV, Vautour R.
    Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
    [Abstract] [Full Text] [Related]

  • 2. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
    Arguedas AG, Arrieta AC, Stutman HR, Akaniro JC, Marks MI.
    J Antimicrob Chemother; 1991 Mar; 27(3):311-8. PubMed ID: 1903788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children].
    Tian HL, Shi W, Zhou HF, Yuan L, Yao KH, Rexiati D, Xu AM.
    Zhonghua Er Ke Za Zhi; 2018 Apr 02; 56(4):279-283. PubMed ID: 29614568
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G.
    Chemotherapy; 1992 Apr 02; 38(1):36-45. PubMed ID: 1618002
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G, Aleo G, Caccamo F, Nicolosi VM, Siracusa V, Speciale A.
    J Chemother; 1996 Jun 02; 8(3):193-9. PubMed ID: 8808715
    [Abstract] [Full Text] [Related]

  • 10. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM, Suter M, Borsos S.
    J Antimicrob Chemother; 1999 Mar 02; 43 Suppl A():25-30. PubMed ID: 10225568
    [Abstract] [Full Text] [Related]

  • 11. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun 02; 50(6):2050-7. PubMed ID: 16723565
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV, Tubert TA.
    Diagn Microbiol Infect Dis; 1990 Jun 02; 13(4):349-52. PubMed ID: 2127558
    [Abstract] [Full Text] [Related]

  • 13. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
    Jones RN, Biedenbach DJ, Croco MA, Barrett MS.
    Diagn Microbiol Infect Dis; 1998 Aug 02; 31(4):573-8. PubMed ID: 9764398
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV.
    Diagn Microbiol Infect Dis; 1991 Aug 02; 14(1):75-7. PubMed ID: 1901536
    [Abstract] [Full Text] [Related]

  • 15. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Yourassowsky E, Van der Linden MP, Crokaert F.
    Chemotherapy; 1992 Aug 02; 38(1):7-13. PubMed ID: 1618006
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
    Johnson DM, Biedenbach DJ, Beach ML, Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jun 02; 37(2):99-105. PubMed ID: 10863104
    [Abstract] [Full Text] [Related]

  • 17. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M, Browne FA, Jacobs MR, Appelbaum PC.
    Clin Ther; 2003 Jan 02; 25(1):169-77. PubMed ID: 12637118
    [Abstract] [Full Text] [Related]

  • 18. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Thornsberry C, Ogilvie P, Kahn J, Mauriz Y.
    Diagn Microbiol Infect Dis; 1997 Dec 02; 29(4):249-57. PubMed ID: 9458982
    [Abstract] [Full Text] [Related]

  • 19. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA, Farrell DJ, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep 02; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [Abstract] [Full Text] [Related]

  • 20. Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.
    Karlowsky JA, Critchley IA, Draghi DC, Jones ME, Thornsberry C, Sahm DF.
    Diagn Microbiol Infect Dis; 2002 Jan 02; 42(1):53-8. PubMed ID: 11821172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.